HDFN: New Understandings of Risk, Diagnosis, and Therapeutic Approaches - a podcast by ReachMD

CME credits: 0.25

Valid until: 28-07-2022

Claim your CME credit at https://reachmd.com/programs/cme/hdfnnew-understandings-risk-diagnosis-and-therapeutic-approaches/12710/

Hemolytic disease of the fetus and newborn (HDFN) is a rare disease that occurs due to the incompatibility between fetal and maternal red cell antigens. HDFN can lead to both short- and long-term consequences, including potentially fatal outcomes. In order to better prevent these associated issues, the timely evaluation, recognition, and treatment of HDFN are critical.

Listen in as three leading experts, Drs. Lee Shulman, Kenneth Moise, and Christopher Robinson, join together to discuss new epidemiologic evidence, the underlying pathophysiology of HDFN, health equity, and evolving management strategies you can implement to improve your clinical practice.

Further episodes of ReachMD CME

Further podcasts by ReachMD

Website of ReachMD